dapi has been researched along with batimastat in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cunningham, LA; Rosenberg, GA; Wetzel, M | 1 |
1 other study(ies) available for dapi and batimastat
Article | Year |
---|---|
Tissue inhibitor of metalloproteinases-3 and matrix metalloproteinase-3 regulate neuronal sensitivity to doxorubicin-induced apoptosis.
Topics: Animals; Antigens, CD; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Caspases; Cell Count; Cells, Cultured; Cerebral Cortex; Doxorubicin; Embryo, Mammalian; fas Receptor; Glial Fibrillary Acidic Protein; Immunoglobulin G; Immunohistochemistry; Indoles; L-Lactate Dehydrogenase; Matrix Metalloproteinase 3; Neurons; Phenylalanine; Phosphopyruvate Hydratase; Precipitin Tests; Rats; Rats, Inbred WKY; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiophenes; Time Factors; Tissue Inhibitor of Metalloproteinase-3 | 2003 |